GT Biopharma, Inc.
Amendment
CIK: 0000109657·Biotechnology·DELAWARE·Filed: Jul 23, 2020
Total Offering
Indefinite
Amount Sold
$5,607,000
Investors
18
First Sale
Apr 20, 2020
Offering Details
- Type
- Debt, Other: Debt convertible into equity.
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Anthony Cataldo | Related Person |
| Steven Weldon | Related Person |
Company
SEC Filing
0001654954-20-007958
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free